Company Filing History:
Years Active: 2021
Title: Innovator Spotlight: Jenny Fitting
Introduction
Jenny Fitting, an accomplished inventor based in Cologne, Germany, is recognized for her contributions to the field of biotechnology. With a notable patent in her portfolio, she is paving the way for innovative treatments in the medical sector.
Latest Patents
Jenny holds a patent for “Antibody drug conjugates of kinesin spindle protein (KSP) inhibitors with anti-B7H3-antibodies.” This groundbreaking application pertains to novel binder drug conjugates (ADCs) aimed at the treatment and/or prophylaxis of various diseases. These include hyperproliferative and/or angiogenic disorders, such as cancer. The patent outlines the processes for preparing these ADCs, highlighting their potential use as monotherapy or in combination with other treatments. The development of such therapies signifies a leap forward in the fight against serious health conditions.
Career Highlights
As an innovator, Jenny Fitting is currently employed at Bayer Pharma Aktiengesellschaft, a leading global pharmaceutical company. Her efforts in research and development have been critical in pushing the boundaries of current medical technologies and treatments.
Collaborations
Throughout her career, Jenny has collaborated with esteemed coworkers including Hans-Georg Lerchen and Anne-Sophie Rebstock. Together, they contribute to a synergistic environment that fosters innovation and progress in the pharmaceutical domain.
Conclusion
Jenny Fitting exemplifies the spirit of innovation essential in the pharmaceutical industry. Her patent reflects a significant step in the development of advanced therapeutic options, targeting critical health challenges. With her dedication and collaborative efforts, she continues to inspire the next generation of inventors and researchers.